» Articles » PMID: 22969245

Subpopulations of Regulatory T Cells in Rheumatoid Arthritis, Systemic Lupus Erythematosus, and Behcet's Disease

Overview
Specialty General Medicine
Date 2012 Sep 13
PMID 22969245
Citations 14
Authors
Affiliations
Soon will be listed here.
Abstract

Recently, subpopulations of regulatory T (Treg) cells, resting Treg (rTreg) and activated Treg (aTreg), have been discovered. The authors investigated the relationship between the change of Treg, aTreg and rTreg and autoimmune diseases. Treg cells and those subpopulations were analyzed by using the human regulatory T cell staining kit and CD45RA surface marker for 42 rheumatoid arthritis (RA), 13 systemic lupus sclerosis (SLE), 7 Behcet's disease (BD), and 22 healthy controls. The proportion of Treg cells was significantly lower in RA (3.8% ± 1.0%) (P < 0.001) and BD (3.3% ± 0.5%) (P < 0.01) compared to healthy controls (5.0% ± 1.3%). The proportion of aTreg cells was also significantly lower in RA (0.4% ± 0.2%) (P = 0.008) and BD (0.3% ± 0.1%) (P = 0.013) compared to healthy controls (0.6% ± 0.3%). The rTreg cells showed no significant differences. The ratio of aTreg to rTreg was lower in RA patients (0.4% ± 0.2%) than that in healthy controls (0.7% ± 0.4%) (P = 0.002). This study suggests that the decrement of aTreg not rTreg cells contributes the decrement of total Treg cells in peripheral blood of RA and BD autoimmune diseases. Detailed analysis of Treg subpopulations would be more informative than total Treg cells in investigating mechanism of autoimmune disease.

Citing Articles

Regulatory T Cells in Autoimmune Vasculitis.

Jin K, Parreau S, Warrington K, Koster M, Berry G, Goronzy J Front Immunol. 2022; 13:844300.

PMID: 35296082 PMC: 8918523. DOI: 10.3389/fimmu.2022.844300.


Changes in peripheral blood T lymphocyte subsets predict disease progression in patients with rheumatoid arthritis.

Tan J, Chen J Am J Transl Res. 2022; 14(2):1068-1075.

PMID: 35273709 PMC: 8902567.


Dysfunctions, Molecular Mechanisms, and Therapeutic Strategies of Regulatory T Cells in Rheumatoid Arthritis.

Li X, Xu H, Huang J, Luo D, Lv S, Lu X Front Pharmacol. 2021; 12:716081.

PMID: 34512345 PMC: 8428974. DOI: 10.3389/fphar.2021.716081.


Analysis of Regulatory T Cell Subsets and Their Expression of Helios and PD-1 in Patients with Hashimoto Thyroiditis.

Hu Y, Zhang L, Chen H, Liu X, Zheng X, Shi H Int J Endocrinol. 2019; 2019:5368473.

PMID: 31214258 PMC: 6535823. DOI: 10.1155/2019/5368473.


Treg cells in autoimmunity: from identification to Treg-based therapies.

Goschl L, Scheinecker C, Bonelli M Semin Immunopathol. 2019; 41(3):301-314.

PMID: 30953162 DOI: 10.1007/s00281-019-00741-8.


References
1.
Zhang B, Zhang X, Tang F, Zhu L, Liu Y . Reduction of forkhead box P3 levels in CD4+CD25high T cells in patients with new-onset systemic lupus erythematosus. Clin Exp Immunol. 2008; 153(2):182-7. PMC: 2492897. DOI: 10.1111/j.1365-2249.2008.03686.x. View

2.
Costantino C, Baecher-Allan C, Hafler D . Human regulatory T cells and autoimmunity. Eur J Immunol. 2008; 38(4):921-4. PMC: 2752283. DOI: 10.1002/eji.200738104. View

3.
Sugita S, Yamada Y, Kaneko S, Horie S, Mochizuki M . Induction of regulatory T cells by infliximab in Behcet's disease. Invest Ophthalmol Vis Sci. 2010; 52(1):476-84. DOI: 10.1167/iovs.10-5916. View

4.
Wouters C, Diegenant C, Ceuppens J, Degreef H, Stevens E . The circulating lymphocyte profiles in patients with discoid lupus erythematosus and systemic lupus erythematosus suggest a pathogenetic relationship. Br J Dermatol. 2004; 150(4):693-700. DOI: 10.1111/j.0007-0963.2004.05883.x. View

5.
Yagi H, Nomura T, Nakamura K, Yamazaki S, Kitawaki T, Hori S . Crucial role of FOXP3 in the development and function of human CD25+CD4+ regulatory T cells. Int Immunol. 2004; 16(11):1643-56. DOI: 10.1093/intimm/dxh165. View